← Insider buys
AIMT

Aimmune Therapeutics, Inc.

GM, Europe Susan E. Barrowcliffe sold $405K of Aimmune Therapeutics, Inc.

Sold$404,615
$22.00Price
18,390Shares
−100%Stake

What AIMT did after the filing

Prices for AIMT after this filing aren't in yet.

Traded Tue, Sep 5. Filed Thu, Sep 7, 12:05 PM ET, during the session. Not investment advice.